Capricor Therapeutics Inc
NASDAQ:CAPR

Watchlist Manager
Capricor Therapeutics Inc Logo
Capricor Therapeutics Inc
NASDAQ:CAPR
Watchlist
Price: 18.16 USD -1.78%
Market Cap: 590.9m USD
Have any thoughts about
Capricor Therapeutics Inc?
Write Note

P/S
Price to Sales

21.4
Current
18
Median
8
Industry
Higher than median
Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
21.4
=
Market Cap
577.6m USD
/
Revenue
27.2m USD
All Countries
Close

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
34.9
2-Years Forward
P/S
11.3
3-Years Forward
P/S
7.1

See Also

Discover More